Over $1M in admin, marketing and staff. 300k more than last quarter but they are watching costs right?
MD is going to continue to cash his check and has NO incentive to progress clinical trials as fast as possible.
here’s some more BS where he is posting timelines that are impossible to hold him to account on:
”The timing of the initiation of the nine-month toxicology study will be dependent on progress of ATL1102 in DMD in Europe and continued interactions on the regulatory path in the US with the FDA.” great, very clear
”Site evaluations had been completed with follow on site selection close to finalization” literally same sentence as investor presentation in May.
”The second study is planned for 3Q/4QCY22”. Is it really that hard to know if you’ll have suitable aged mice and get a fixed timeline. Last I checked time was linear?
And, NO MENTION OF COVID????
how much confidence does this really give?
- Forums
- ASX - By Stock
- PER
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
7.9¢ | 8.0¢ | 7.9¢ | $12.63K | 158.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66500 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 273231 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66500 | 0.076 |
4 | 206988 | 0.075 |
2 | 353708 | 0.074 |
1 | 100000 | 0.072 |
2 | 310000 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 273231 | 2 |
0.082 | 255785 | 2 |
0.083 | 110520 | 2 |
0.084 | 157142 | 2 |
0.085 | 553000 | 3 |
Last trade - 15.26pm 19/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |